PATENT CLAIM ANALYSIS

Application Number: 15865037
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "186100"]

Abstract:
The present invention provides system and methods for detecting an analyte indicative of an influenza viral infection in a sample of bodily fluid. The present invention also provides for systems and method for detection a plurality of analytes, at least two of which are indicative of an influenza viral infection in a sample of bodily fluid.

Claim (Index 89):
The fluidic device of  claim 85 , wherein the hemagglutinin is selected from the group consisting of H1, H2, H3, H4, H5, H6, H7, H8, H9, H10, H11, H12, H13, H14, H15, and H16, and the neuraminidase is selected from the group consisting of N1, N2, N3, N4, and N5.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 86.0
- Lexical Diversity: 1.73529
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13187960', '11746535', '11389409', '12750518', '14868208']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7999552886776539
- 35 USC 102 Novelty (BERT): 0.599276591502558
- Combined Prediction Score: 0.7798874189601442
- Mean Citation Score: 377.66397799999993
- Max Citation Score: 544.4576400000002
- Similarity Product: 473.2604246233609

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test